# UNH — slm-full-cpu

## Metadata

ticker: UNH
arm: slm-full-cpu
judge_prompt_version: v2
context_sha256: 1857a1584b143d68cc64e6aae79161d046c21134506f22c964dbc50f708d7699
slm_endpoint: slm-cpu
slm_url: http://llamacpp.financial-agent.svc:8080
slm_served_name: qwen3.6-35b-a3b-q4km
slm_artifact: ggml-org/Qwen3.6-35B-A3B-GGUF@baec3ebee244827cda0f4557eafa8b28f7545fa6:Qwen3.6-35B-A3B-Q4_K_M.gguf sha256:671e47e0ec53c665d048b98c3ecbfd5236b5ca9c3e02ed19fc8f81f7b85140c7
slm_build: b11347-5fc4f3c8c
slm_model_path: /models/Qwen3.6-35B-A3B-Q4_K_M.gguf
slm_model_ftype: Q4_K - Medium
slm_total_slots: 4
slm_n_ctx: 32768
slm_n_params: 34660610688
slm_model_size_bytes: 20408576512
slm_thinking: off
slm_sampling: {"planner": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "rag": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 2048, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "react": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "section": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 768, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "synthesis": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 4096, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.2, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}}
llm_calls: 7
llm_endpoints: slm-cpu
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 647, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 149.21, "latency_s_total": 149.21, "parse_failure": 0, "prompt_tokens": 3060, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 418, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 124.259, "latency_s_total": 124.259, "parse_failure": 0, "prompt_tokens": 3049, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 154, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 48.49, "latency_s_total": 48.49, "parse_failure": 0, "prompt_tokens": 861, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 99, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 33.926, "latency_s_total": 33.926, "parse_failure": 0, "prompt_tokens": 855, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 168, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 50.131, "latency_s_total": 50.131, "parse_failure": 0, "prompt_tokens": 489, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 127, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 56.658, "latency_s_total": 56.658, "parse_failure": 0, "prompt_tokens": 726, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 794, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 136.587, "latency_s_total": 136.587, "parse_failure": 0, "prompt_tokens": 1472, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 375.405,
  "currency": "USD",
  "market_cap": 336961568768.0,
  "pe_ratio": 24.1418,
  "forward_pe": 16.603355,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "financial_currency": "USD",
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin_pct": 3.14,
  "dividend_yield": 2.45,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] Based on the provided risk factors from the Annual Report on Form 10-K for UNH, the key takeaways regarding potential risks to the company’s business, financial position, and operations include:

**1. Medical Cost Management and Pricing Risks**
*   **Profitability Dependence:** The profitability of risk-based products, which constitute nearly 80% of total consolidated revenues, relies heavily on the ability to accurately predict, price, and manage medical and administrative costs.
*   **Estimation Variability:** Benefit expense estimates involve significant judgment and variability. Small differences between predicted and actual medical costs or utilization rates can lead to significant changes in financial results.
*   **Unrecoverable Cost Increases:** Actual costs may exceed estimates due to factors such as medical cost inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, new costly drugs or technologies, and regulatory changes. These excess costs typically cannot be recovered through higher premiums during the fixed contract period.
*   **Value-Based Care Challenges:** For Optum Health’s fully accountable value-based arrangements, failure to deliver higher-quality outcomes and better experiences at lower costs, or failure to integrate care delivery models, could adversely affect financial results.

**2. Cybersecurity and Data Privacy Risks**
*   **Cyberattacks and Data Breaches:** The company faces ongoing risks from cyberattacks, privacy incidents, and data security breaches, which could result in revenue loss, increased costs, liability, reputational harm, and operational disruptions. A notable example cited is a 2024 cyberattack on the acquired Change Healthcare business involving protected health information.
*   **Evolving Threats:** Threat actors are increasingly sophisticated, utilizing evolving AI technologies (including generative AI) to penetrate security controls, deploy malicious code (such as ransomware), and disrupt systems.
*   **Third-Party and Integration Risks:** Reliance on third-party vendors for data processing introduces risks outside direct oversight. Additionally, recently acquired or non-integrated businesses may present heightened vulnerabilities.
*   **Regulatory Compliance:** Uncertain and rapidly evolving laws regarding health data and AI may impose new compliance requirements, alter the competitive landscape, and affect the configuration of information systems.

**3. Technology Systems and Data Integrity**
*   **System Integration and Upgrades:** Failure to successfully consolidate, integrate, upgrade, or expand information systems could result in higher-than-expected costs. Software products sold or installed may contain design defects or encounter complications during installation or integration with other technologies.
*   **Data Accuracy and Availability:** The business depends on the integrity, timeliness, and accuracy of data. Inaccurate, incomplete, or outdated data could lead to failures in health and IT products, loss of customers, difficulties in pricing and fraud prevention, regulatory sanctions, and increased operating expenses.
*   **AI and Technological Pace:** The company anticipates that fast-evolving AI technologies will play an increasingly important role. However, failing to keep pace with technological changes, regulatory standards, or customer preferences could lead to reputational harm and adverse business effects. The cost of keeping pace with these changes may exceed estimates.

RAG — RISK FACTORS:
[From Pinecone cache] The primary risk factors disclosed include:

*   **Inaccurate Cost Estimation and Management:** Failure to accurately predict, price, or manage medical costs and administrative expenses for risk-based products could materially and adversely affect financial results. This is particularly relevant because premium revenues from these products constitute nearly 80% of total consolidated revenues. Factors causing actual costs to exceed estimates include medical cost inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, new or costly drugs, and regulatory changes. Additionally, estimates for outstanding claims involve significant judgment, and inaccuracies can negatively impact operations.
*   **Technology and Data Integrity Risks:** The business relies heavily on the integrity, timeliness, and availability of data. Risks include failures in health, wellness, and IT products; loss of customers; difficulty in pricing and fraud detection; and regulatory sanctions. Specific challenges involve consolidating, integrating, and upgrading information systems, as well as keeping pace with fast-evolving technologies like artificial intelligence (AI) and generative AI. Failure to successfully implement these initiatives or protect data integrity could result in higher costs, reputational harm, and adverse operational effects.
*   **Cybersecurity and Data Privacy Incidents:** The company faces risks from cyberattacks, privacy breaches, and data security incidents involving protected personal information and proprietary data. These incidents could lead to revenue loss, increased costs, liability, reputational harm, and operational disruptions. The sophistication of threats, including those leveraging AI, and vulnerabilities in third-party vendors or recently acquired businesses (such as the 2024 cyberattack on Change Healthcare) exacerbate these risks.
*   **Provider and Payer Relationships:** Failure to develop and maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers could materially and adversely affect the business.
*   **Value-Based Care Performance:** For Optum Health’s fully accountable value-based care, an inability to provide higher-quality outcomes and better experiences at lower costs, or to successfully integrate care delivery models, could negatively impact results.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group (UNH) trades at $375.41 with a market capitalization of approximately $337 billion, reflecting its dominant position in the healthcare sector. The company reports annual revenue of $450.5 billion and a net income of $14.1 billion, resulting in a profit margin of 3.14%. While the trailing P/E ratio stands at 24.14, the forward P/E of 16.60 suggests anticipated earnings growth and a more attractive valuation relative to future performance. This divergence indicates that the market expects improved profitability or earnings expansion in the coming year. Overall, the financial profile demonstrates strong top-line scale with improving forward-looking valuation metrics.

### Recent Developments

UnitedHealth Group has filed its 2026 10-K and 10-Q reports, with the latter confirming no material changes to the risk factors previously disclosed in the annual filing. The company continues to execute its capital return strategy, as evidenced by ongoing share repurchase activities detailed in the second quarter of 2026. Investors should monitor these filings for any emerging regulatory or operational risks that could impact the firm's strong forward valuation metrics.

### SEC Filing Highlights
UnitedHealth Group’s profitability remains heavily dependent on accurately managing medical costs for its risk-based products, which constitute nearly 80% of total revenues, as actual expenses often exceed estimates due to inflation and utilization trends. The company faces significant cybersecurity and data privacy risks, highlighted by the 2024 Change Healthcare breach, which could result in substantial financial liability and operational disruptions amid evolving AI-driven threats. Additionally, successful integration of technology systems and maintenance of data integrity are critical, as failures in these areas or an inability to keep pace with rapid technological advancements could adversely impact financial results and regulatory compliance.

### Risk Factors

*   **Inaccurate Cost Estimation:** Failure to accurately predict medical costs and administrative expenses for risk-based products, which constitute nearly 80% of total revenues, could materially adversely affect financial results due to factors like medical inflation, utilization changes, and regulatory shifts.
*   **Cybersecurity and Data Integrity:** The company faces significant risks from cyberattacks, privacy breaches, and data security incidents, including those involving third-party vendors and recently acquired businesses, which could lead to revenue loss, liability, and operational disruptions.
*   **Technology and AI Implementation:** Heavy reliance on the integrity and timeliness of data, combined with the challenge of integrating fast-evolving technologies like artificial intelligence, poses risks of higher costs, reputational harm, and regulatory sanctions if systems fail or are not successfully upgraded.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group is a dominant force in the healthcare sector, generating $450.5 billion in annual revenue and maintaining a market capitalization of approximately $337 billion. The stock is currently notable for its attractive forward valuation, with a forward P/E of 16.60 suggesting anticipated earnings growth despite a higher trailing multiple. The single most important near-term variable shaping the investment outcome is the company’s ability to accurately manage medical costs for its risk-based products, which constitute nearly 80% of total revenues.

### Outlook
The directional outlook for UnitedHealth Group is cautiously constructive, supported by a compelling forward valuation that prices in expected earnings expansion. Key variables to monitor include the trend in medical cost ratios, the execution of capital return strategies through share repurchases, and the firm's resilience against evolving cybersecurity threats and regulatory pressures. The thesis would be strengthened by consistent margin stability and successful integration of technological advancements, while a deterioration in cost estimation accuracy or a significant operational disruption from data security incidents would weaken the investment case.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically identify every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections, then evaluate each.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "$450.5 billion in annual revenue"
LABEL: SUPPORTED
REASON: Source data shows revenue of $450,525,986,816, which rounds to $450.5 billion; the Pre-written Financial Health section also states "annual revenue of $450.5 billion."

---

CLAIM: "market capitalization of approximately $337 billion"
LABEL: SUPPORTED
REASON: Source data shows market_cap of $336,961,568,768, which rounds to approximately $337 billion; confirmed in the Financial Health section.

---

CLAIM: "forward P/E of 16.60"
LABEL: SUPPORTED
REASON: Source data shows forward_pe of 16.603355, which rounds to 16.60; confirmed in the Financial Health section.

---

CLAIM: "nearly 80% of total revenues" (risk-based products)
LABEL: SUPPORTED
REASON: The RAG SEC Highlights, RAG Risk Factors, SEC Filing Highlights pre-written section, and Risk Factors pre-written section all explicitly state risk-based products "constitute nearly 80% of total consolidated revenues."

---

**OUTLOOK**

---

CLAIM: "forward valuation that prices in expected earnings expansion"
LABEL: INFERENCE
REASON: The forward P/E of 16.60 is materially lower than the trailing P/E of 24.14 (both present in source data), and the Financial Health section explicitly states this divergence "indicates that the market expects improved profitability or earnings expansion," making this a direct restatement of a conclusion drawn in the pre-written section from two present figures.

---

CLAIM: "execution of capital return strategies through share repurchases"
LABEL: SUPPORTED
REASON: The 10-Q filing summary explicitly references "Issuer Purchases of Equity Securities" and "Second Quarter 2026" share repurchase activity, and the Recent Developments section confirms "ongoing share repurchase activities detailed in the second quarter of 2026."

---

*(No additional standalone quantitative figures, price targets, specific thresholds, named product milestones, or forward-looking numbers appear in the Outlook section beyond those already evaluated above.)*

---

**SUMMARY TABLE**

| # | Claim | Label |
|---|-------|-------|
| 1 | $450.5 billion in annual revenue | SUPPORTED |
| 2 | Market cap ~$337 billion | SUPPORTED |
| 3 | Forward P/E of 16.60 | SUPPORTED |
| 4 | Nearly 80% of total revenues (risk-based products) | SUPPORTED |
| 5 | Forward valuation prices in expected earnings expansion | INFERENCE |
| 6 | Capital return strategies through share repurchases | SUPPORTED |
